Clinical Trial Update: Observational Study of the Effects Intravenous Bortezomib Has on Osteoblast (Cell That is Responsible for Bone Formation) Activity in Multiple Myeloma Patients.

View source ↗

Summary

An observational study evaluating the effects of intravenous bortezomib on osteoblast activity in patients with multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Multiple Myeloma | Status: COMPLETED